Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-02-27
1979-02-13
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260558A, 260558D, 260558P, 260559A, 424 15, 424324, A61K 2902, C07C10324, C07C10326, C07C10328
Patent
active
041396057
ABSTRACT:
.alpha., .omega.-BIS-[5-(DIHYDROXYALKYL) AMINOCARBONYL-3-HYDROXYACYL-AMINO-2,4,6-TRIIODO-BENZOYL-AMINO]-OXAALKANE COMPOUNDS OF THE FORMULA ##STR1## wherein R.sub.1 is ##STR2## R and R' are hydrogen or methyl, R.sub.2 is dihydroxyalkyl having 3 or 4 carbon atoms,
REFERENCES:
patent: 3660469 (1972-05-01), Bernstein et al.
patent: 3953501 (1976-04-01), Klieger et al.
patent: 4001323 (1977-01-01), Felder et al.
patent: 4005188 (1977-01-01), Tilly et al.
patent: 4014986 (1977-03-01), Tilly et al.
patent: 4032567 (1977-06-01), Klieger et al.
patent: 4062934 (1977-12-01), Tilly et al.
Felder Ernst
Pitre Davide
Berman Hans
Bracco - Industria Chimica S.p.A.
Clarke Vera C.
Meyers Albert T.
LandOfFree
Water-soluble, non-ionizing, radiopaque compounds and contrast c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Water-soluble, non-ionizing, radiopaque compounds and contrast c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Water-soluble, non-ionizing, radiopaque compounds and contrast c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-691449